Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel R Crooks

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Journal of Experimental & Clinical Cancer Research : CR|April 24, 2023
High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinomaMartin Lang, Laura S Schmidt, Kelli M Wilson, et al.
Science Signaling|January 6, 2021
Mitochondrial DNA alterations underlie an irreversible shift to aerobic glycolysis in fumarate hydratase-deficient renal cancerDaniel R Crooks, Nunziata Maio, Martin Lang, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2025
Impaired oxidative phosphorylation drives primary tumor escape and metastasisEmily N Arner, Erin Q Jennings, Daniel R Crooks, et al.
Molecular Cancer Therapeutics|October 14, 2024
Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the Novel NAMPT Inhibitor OT-82Susana S Najera, Christopher J Ricketts, Laura S Schmidt, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Journal of Experimental & Clinical Cancer Research : CR|April 24, 2023
High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinomaMartin Lang, Laura S Schmidt, Kelli M Wilson, et al.
Science Signaling|January 6, 2021
Mitochondrial DNA alterations underlie an irreversible shift to aerobic glycolysis in fumarate hydratase-deficient renal cancerDaniel R Crooks, Nunziata Maio, Martin Lang, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2025
Impaired oxidative phosphorylation drives primary tumor escape and metastasisEmily N Arner, Erin Q Jennings, Daniel R Crooks, et al.
Molecular Cancer Therapeutics|October 14, 2024
Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the Novel NAMPT Inhibitor OT-82Susana S Najera, Christopher J Ricketts, Laura S Schmidt, et al.
Pageof 6